COMMUNIQUÉS West-GlobeNewswire

Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
09/04/2025
NDA Submission Anticipated Q2 Calendar 2025 PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx- [...]
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors
09/04/2025
Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr [...]
World Leaders in Proteomics and Proteoform Biology to Convene at the 3rd International Top-Down Proteomics Symposium
09/04/2025
The Symposium will feature scientific leaders who are creating cutting edge technologies and approaches for building the bridge from genotype to phenotype. This is ushering in the era of proteoform-specific biology [...]
Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95
09/04/2025
CT-95 is a mesothelin x CD3 T cell engaging bispecific antibody CT-95 is Context’s second T cell engaging bispecific antibody to enter the clinic in 2025 PHILADELPHIA, April 09, 2025 (GLOBE NEWSWIRE) -- Context [...]
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
09/04/2025
Action Taken to Maintain Company’s Nasdaq Listing DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date [...]
Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
09/04/2025
FDA Approves EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy Total Revenue $19 million, representing +17% growth year over year FDA Approves Prior Approval [...]
Theratechnologies présente ses résultats financiers pour le premier trimestre de 2025 et passe en revue ses principales réalisations
09/04/2025
La FDA approuve EGRIFTA WR MC (la formulation F8 de la tésamoréline) pour traiter l’excès de graisse viscérale abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie Les revenus totaux s’élèvent à 19 [...]
Beta Bionics to Host Investor Event on June 22, 2025
09/04/2025
IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it will host [...]
Mars Veterinary Health Underscores Long-Term Commitment to Research & Innovation in Groundbreaking Science Impact Report
09/04/2025
Global leader in peer-reviewed veterinary research highlights progress in advancing veterinary science and clinical excellence through inaugural science report launch BIRMINGHAM, England, April 09, 2025 (GLOBE NEWSWIRE [...]
Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer
09/04/2025
WATERTOWN, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub
09/04/2025
Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 BROOMFIELD, Colo., April 09, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology [...]
Dentsply Sirona to Host First Quarter Conference Call on May 8th
09/04/2025
CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast [...]
KSQ Therapeutics Announces First Patient Dosed in Phase 1/2 Study for KSQ-004EX, a CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy
09/04/2025
Phase 1/2 clinical study will evaluate the safety and preliminary efficacy of KSQ-004EX in advanced solid tumors LEXINGTON, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- KSQ Therapeutics, Inc. (KSQ), a clinical-stage [...]
Microbix Exhibiting at ESCMID Global 2025
09/04/2025
Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program Results MISSISSAUGA, Ontario, April 09, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences [...]
Preliminary results for the year ended 31 December 2024
09/04/2025
~ Strong commercial momentum underpins transformative financial performance ~ Strong 2024 financial performance in line with guidance Revenue growth of 44% to £128.8 million compared to 2023, organic revenue growth of [...]
Atea Pharmaceuticals Announces Dosing of First Patient in C-BEYOND, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
09/04/2025
Regimen has Potential Best-in-Class Profile with Short Treatment Duration, Low Risk for Drug-Drug Interactions and Convenience with No Food Effect HCV Infection Remains a Significant Global Health Burden, with [...]
American Shared Hospital Services to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub
09/04/2025
Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of [...]
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
09/04/2025
WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives [...]
Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies
09/04/2025
Agreement includes the use of Tonix’s TNX-1500, as part of an immunomodulatory regimen to reduce rejection of Makana’s genetically engineered pig organs in xenotransplantation Establishes framework for Makana’s kidney, [...]

Pages